CBM Reviews May Fade Away As Fed. Circ. Limits Reach

Law360, New York (March 10, 2017, 11:04 PM EST) -- The America Invents Act’s covered business method review program has been a popular way for accused infringers to target patents they believe are invalid under Alice, but recent Federal Circuit rulings restricting when the program can be used may cause interest to dwindle, attorneys say.

The CBM program allows the Patent Trial and Appeal Board to review the validity of patents used in financial products and services under grounds not available in inter partes reviews, including patent-eligibility arguments like the U.S. Supreme Court’s Alice ruling. But...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.